Jacob Corn

Do you work in #cancer and feel behind-the-curve in #CRISPR state of the art? Get up to speed fast with this review! Huge kudos to Joshua Casan, Samuel Grigg, and Carolyn Shembrey for heavy lifting to pull this together. www.nature.com/articles/s41...

Do you need a super active #CRISPR Cas for in vivo editing? I have not one, but two options for you. Activities rival SpyCas9, but they fit into an scAAV. Check out our latest paper, co-led by Fedor Gorbenko and Irene Sala. Just out in Genome Research. link.springer.com/article/10.1...

I'm very excited to be part of the new #NCCR Children & Cancer. This amazing group spans all of #Switzerland to unite researchers & clinical practitioners to tackle deadly childhood cancers. Website is live today - stay tuned for #hiring and research updates childrenandcancer.ch

New lab preprint - Common and rare variant studies for the same trait identify different genes and here Diederik Laman Trip developed a protein network AI enconding to investigate if traits studied by different approaches converge on the same molecular pathways www.biorxiv.org/content/10.6...

The preliminary program and registration is open for SwissPR 2026, happening in Basel at the Biozentrum on 30th June. Hear from @jpkbravo.bsky.social , Jonathan Schmid-Burgk, Julian Grünewald, @martinpacesa.bsky.social, and more. Register now at www.swisspr-symposium.uzh.ch/en.html

Excited to share our discovery of a new programmable RNA-guided DNA-targeting system hiding inside bacteriophages that predates CRISPR. We call it VIPR (Viral Interference Programmable Repeat), and it uses an entirely new logic to find its targets. Thread + link below.

The E3 ubiquitin ligase mechanism specifying target-directed microRNA degradation (TDMD) is now published! 🎉🍾 We, @bartellab.bsky.social and Schulman lab, describe how 2-RNA factors control protein degradation by recruiting an E3 ligase. @mpibiochem.bsky.social www.nature.com/articles/s41...

It’s been a fun first few week of my sabbatical. Many exciting meetings w/ @peterfineran.bsky.social lab, learning new stuff and brainstorming ideas. And my own lab has been off to a crazy great start to the year. The early/late zoom meetings have me burning the candle at both ends…

Dunedin welcomed me to my sabbatical at @universityofotago.bsky.social with @peterfineran.bsky.social with style.

www.nature.com/articles/d41...

Sometimes I'm excited to read a paper and every paragraph blows me away. And sometimes I'm just as excited and every paragraph leaves me wondering if the referees were sleeping on the job. Today it was one of the latter.

ERC Plus Grants • No career limit, current ERCs are not eligible • Major challenge, transformative research • Up to 7 million euros, up to 7 years • 30 grants per year, 2 years, only once per lifetime • Same application format, plus vision statement • Deadline in September 2026, 2 stage evaluation

What controls expansion & contraction of DNA repeats (e.g. Huntington's)? We were thrilled to collaborate w/ the lab of Marta Olejniczak to find out. Check out the cool screen from @sebasiegner.bsky.social and @matthiasmuhar.bsky.social that reads out repeat sequence. www.biorxiv.org/content/10.1...

I’m very grateful to @ethz.ch @vseth.ethz.ch.web.brid.gy for a Golden Owl award. People who know me know that I respectfully decline science awards. But recognition directly by students hits different!

Congratulations to @sebasiegner.bsky.social who defended his PhD on Friday! His name will be on 6-7 papers by the time he leaves the lab, including a co-first Nature paper. What a superstar! Keep an eye out for his postdoc application 😉

It has been disappointing to see the general lack of interest and investment into population genetics and genomic medicine in Switzerland. While we can resort to other national cohorts for research the country can only benefit if the know-how can be applied locally www.sfa-phrt.ch/success-stor...

957 proposals were submitted in the latest round of ERC Synergy applications. They expect to fund 50 which means around 5% success rate. This is really not sustainable and a lot of people are likely avoiding doing this knowing how poor the chances are. erc.europa.eu/news-events/...

Congrats to Moritz Schlapansky, who successfully defended his PhD thesis on Friday! You can read his work on "scOUT-seq" profiling of single cell transcriptomes + editing outcomes in millions of cells and living mice at www.biorxiv.org/content/10.1...

In 2026 I'm taking a sabbatical in @peterfineran.bsky.social lab @universityofotago.bsky.social. I'm looking forward to learning a lot from Peter's lab and excited to get back to my prokaryotic/viral roots! Also planning to some trips to the rest of the Pacific and Asia. So much to look forward to!

Thanks to CRISPR/Cas technology, researchers can precisely edit genetic material to treat hereditary diseases. To achieve this, they need to identify undesirable cuts in the genome at an early juncture. Pioneer Fellow Lilly van de Venn is developing such testing methods. ethz.ch/en/news-and-...

Long time no see, everyone! Things have been a bit more busy than ususal, hence the radio silence. But stay tuned for some fun news in the next few days.

Excited to share our latest preprint. Work led by PhD student @jordancjwilson.bsky.social with @profmarciniak.bsky.social, @villungerlab.bsky.social & our @erc.europa.eu partners @jcornlab.bsky.social & @loizoulab.bsky.social, that sheds light on the action of WEE1 inhibitors. bit.ly/4bDpxZl

Do you want to know about the invisible secrets of #HDR during #CRISPR genome editing? Check out our preprint at www.biorxiv.org/content/10.1.... New methods, crazy biology, and theft from the genome! From PhD student @charlesyeh.bsky.social